Pituitary & hypothalamus

Headache relief following endoscopic drainage of Rathke’s cleft cyst

PituitaryPublished Longitudinal cohort study

Authors' conclusion

In the largest prospective study using a validated headache metric, endoscopic endonasal drainage of RCC may improve headache at 6 and 12 months post-operatively, providing long lasting relief. Surgery causes a transient worsening of QOL that resolves after 6 weeks. Headache burden directly correlated with QOL.

Study context

Population
Patients undergoing endoscopic endonasal drainage of Rathke's cleft cyst (Rathke's cleft cysts (RCC)), 2017–202424 with Headache Impact Test (HIT-6) data
Participants
64 patients
Exposure
Post-operative vs pre-operative HIT-6 after endoscopic endonasal drainage of RCC
Outcome
Headache burden (HIT-6 score)
Methodological detailsprospectively collected database
  • Prospectively collected database

Main finding

As reported in the abstract

Change in HIT-6 score vs pre-operatively, adjusted for age · 6 months

HIT-6 score reduced by (points)

5

95% CI −0.3, −9.0p = 0.04

Observational data: associations, not effects.

Further findings

Headache pre-operatively (HIT-6 > 36) · pre-operative

Had headache pre-operatively
67%

HIT-6 change in patients with pre-operative headache · 6 and 12 months

Mean HIT-6 reduction at 6 months (points)
7 (p < 0.05)
Mean HIT-6 reduction at 12 months (points)
6 (p < 0.05)

Predictors of headache change

No association with sex, pre-operative pituitary dysfunction, cyst location, size, MRI signal, histopathology or reoperation

QOL (ABSQ)

Higher HIT-6 associated with worse ABSQ at 12 months
P = 0.01
Overall QOL decreased within first 6 weeks postoperatively, then returned to baseline

Original publication

Headache relief following endoscopic drainage of Rathke’s cleft cyst. Pituitary. Published 13 March 2025. doi:10.1007/s11102-025-01511-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.